125 related articles for article (PubMed ID: 26367222)
1. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.
Ehrhardt MJ; Brazauskas R; He W; Rizzo JD; Shaw BE
Bone Marrow Transplant; 2016 Jan; 51(1):83-8. PubMed ID: 26367222
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation.
Inamoto Y; Matsuda T; Tabuchi K; Kurosawa S; Nakasone H; Nishimori H; Yamasaki S; Doki N; Iwato K; Mori T; Takahashi S; Yabe H; Kohno A; Nakamae H; Sakura T; Hashimoto H; Sugita J; Ago H; Fukuda T; Ichinohe T; Atsuta Y; Yamashita T;
Blood Adv; 2018 Aug; 2(15):1901-1913. PubMed ID: 30087108
[TBL] [Abstract][Full Text] [Related]
4. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
Gallagher G; Forrest DL
Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
[TBL] [Abstract][Full Text] [Related]
5. Secondary cancers following allogeneic haematopoietic cell transplantation in adults.
Majhail NS
Br J Haematol; 2011 Aug; 154(3):301-10. PubMed ID: 21615719
[TBL] [Abstract][Full Text] [Related]
6. Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
Martin A; Schneiderman J; Helenowski IB; Morgan E; Dilley K; Danner-Koptik K; Hatahet M; Shimada H; Cohn SL; Kletzel M; Hijiya N
Pediatr Blood Cancer; 2014 Aug; 61(8):1350-6. PubMed ID: 24634399
[TBL] [Abstract][Full Text] [Related]
7. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem-cell transplantation following solid-organ transplantation in children.
Schechter T; Gassas A; Weitzman S; Grant D; Pollock-BarZiv S; Dipchand A; Alexander S; Ali M; Avitzur Y; Doyle J
Bone Marrow Transplant; 2011 Oct; 46(10):1321-5. PubMed ID: 21822316
[TBL] [Abstract][Full Text] [Related]
9. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
Boehm A; Sperr WR; Leitner G; Worel N; Oehler L; Jaeger E; Mitterbauer M; Haas OA; Valent P; Kalhs P; Rabitsch W
Eur J Clin Invest; 2008 Dec; 38(12):945-52. PubMed ID: 19021720
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
[TBL] [Abstract][Full Text] [Related]
12. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia.
Witherspoon RP; Deeg HJ
Haematologica; 1999 Dec; 84(12):1085-7. PubMed ID: 10586209
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
15. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
[TBL] [Abstract][Full Text] [Related]
16. Solid organ transplantation in survivors of hematopoietic cell transplantation: a single institution case series and literature review.
Beitinjaneh A; Burns LJ; Majhail NS
Clin Transplant; 2010; 24(4):E94-102. PubMed ID: 19919608
[TBL] [Abstract][Full Text] [Related]
17. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
Adhikari J; Sharma P; Bhatt VR
Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
[TBL] [Abstract][Full Text] [Related]
18. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning.
Freycon F; Trombert-Paviot B; Casagranda L; Frappaz D; Mialou V; Armari-Alla C; Gomez F; Faure-Conter C; Plantaz D; Berger C;
Pediatr Hematol Oncol; 2014 Apr; 31(3):225-36. PubMed ID: 24087985
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
